REQUEST A DEMO
Total
USD $0.00
Search more companies

Terapex CIA Ltda (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Terapex CIA Ltda Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Terapex CIA Ltda is an enterprise based in Ecuador. Its main office is in Cumbaya. The company operates in the General Medical and Surgical Hospitals sector. The company was established on March 15, 2012. 3 (2021) employees currently work for Terapex CIA Ltda. In 2022, the company reported a net sales revenue increase of 37.27%. There was a total negative growth of 14.4% in Terapex CIA Ltda’s total assets over the same period. The enterprise’s net profit margin increased by 1.69% in 2022.

Headquarters
Via Lactea N3-17, Casa Bldg. , Floor 1
Cumbaya; Pichincha;

Contact Details: Purchase the Terapex CIA Ltda report to view the information.

Website: http://www.physsio.com.ec

Basic Information
Total Employees:
Purchase the Terapex CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Terapex CIA Ltda report to view the information.
Registered Capital:
Purchase the Terapex CIA Ltda report to view the information.
Incorporation Date:
March 15, 2012
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.75%
Purchase this report to view the information.
0.25%
Company Performance
Financial values in the chart are available after Terapex CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
37.27%
Total operating revenue
37.27%
Operating profit (EBIT)
5483.15%
EBITDA
1244.73%
Net Profit (Loss) for the Period
502.08%
Total assets
-14.4%
Total equity
71.2%
Operating Profit Margin (ROS)
23.34%
Net Profit Margin
1.69%
Return on Equity (ROE)
34.32%
Quick Ratio
0.01%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?